Cargando…
Peanut Allergen Threshold Study (PATS): validation of eliciting doses using a novel single-dose challenge protocol
BACKGROUND: The eliciting dose (ED) for a peanut allergic reaction in 5% of the peanut allergic population, the ED05, is 1.5 mg of peanut protein. This ED05 was derived from oral food challenges (OFC) that use graded, incremental doses administered at fixed time intervals. Individual patients’ thres...
Autores principales: | Zurzolo, Giovanni A, Allen, Katrina J, Taylor, Steve L, Shreffler, Wayne G, Baumert, Joseph L, Tang, Mimi L K, Gurrin, Lyle C, Mathai, Michael L, Nordlee, Julie A, DunnGalvin, Audrey, Hourihane, Jonathan O’B |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850217/ https://www.ncbi.nlm.nih.gov/pubmed/24028324 http://dx.doi.org/10.1186/1710-1492-9-35 |
Ejemplares similares
-
The Emperor Has No Symptoms: The Risks of a Blanket Approach to Using Epinephrine Autoinjectors for All Allergic Reactions
por: Turner, Paul J., et al.
Publicado: (2016) -
Psychometric parameters of food allergy quality of life during an allergen immunotherapy trial
por: Lins de Holanda Coelho, Gabriel, et al.
Publicado: (2022) -
Conformational stability of digestion-resistant peptides of peanut conglutins reveals the molecular basis of their allergenicity
por: Apostolovic, Danijela, et al.
Publicado: (2016) -
A 24-h helpline for access to expert management advice for food allergy-related anaphylaxis in children: protocol for a pragmatic randomised controlled trial
por: Kelleher, Maeve M, et al.
Publicado: (2012) -
Study protocol of a multicentre, randomised, controlled trial evaluating the effectiveness of probiotic and peanut oral immunotherapy (PPOIT) in inducing desensitisation or tolerance in children with peanut allergy compared with oral immunotherapy (OIT) alone and with placebo (the PPOIT-003 study)
por: Chebar Lozinsky, Adriana, et al.
Publicado: (2020)